Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
miR-30b-3p underexpression
Cancer:
Glioblastoma
Drug:
temozolomide
(
DNA synthesis inhibitor
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: C3 – Early Trials
New
Source:
Theranostics
Title:
Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p
Published date:
01/01/2021
Excerpt:
…our cohort showed that patients with low miR-30b-3p expression exhibited a prolonged survival after TMZ therapy…
DOI:
10.7150/thno.47057
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login